Related Experiment Video
Updated: Aug 5, 2026
11:19
Spatiotemporal Analysis of Cytokinetic Events in Fission Yeast
Published on: February 20, 2017
Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins
A Karaiskou1, L H Perez, I Ferby
1European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
The Journal of Biological Chemistry
|July 20, 2001
Summary
A novel regulator, RINGO, activates cyclin-dependent kinases (Cdks) independently of cyclin binding and phosphorylation. Cdk-RINGO complexes evade common inhibitory mechanisms, suggesting distinct roles in cell cycle regulation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cyclin-dependent kinases (Cdks) are crucial for cell cycle progression.
- Cdk activity is tightly regulated by cyclins, phosphorylation, and inhibitory proteins.
- Existing Cdk regulation mechanisms involve specific phosphorylation sites and cyclin partners.
Purpose of the Study:
- To investigate the novel Cdc2 regulator, RINGO, identified in Xenopus oocytes.
- To determine the mechanism of Cdk activation by RINGO.
- To compare the regulatory properties of Cdk-RINGO complexes with Cdk-cyclin complexes.
Main Methods:
- Biochemical assays to measure Cdk kinase activity.
- Analysis of Cdk phosphorylation status.
- Studies on the interaction of Cdk-RINGO complexes with inhibitors like p21(Cip1) and Myt1.
Main Results:
- RINGO activates Cdc2 and Cdk2 without requiring Thr-161/160 phosphorylation.
- Cdk-RINGO complexes are resistant to inhibition by p21(Cip1).
- Myt1 shows reduced efficiency in inhibiting Cdc2-RINGO complexes.
Conclusions:
- RINGO represents a novel class of Cdk activators distinct from cyclins.
- Cdk-RINGO complexes possess unique regulatory properties, enabling activity under conditions inhibitory to Cdk-cyclin complexes.
- These findings suggest alternative pathways for Cdk-mediated cell cycle control.
Related Concept Videos
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...